Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8 + -to-CD3 + ratio remains debatable
Tumor Biology · 05.07.2022 · 44 (1) · 37-52
DOI: 10.3233/tub-211571 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tumor Biology, online erschienen am 07.04.2022. Verfasst von Jussi Kasurinen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
BACKGROUND: A large number of infiltrating CD3- and CD8-positive inflammatory cells indicates an improved survival in colorectal cancer (CRC), similar to many other cancers. OBJECTIVE: We investigated the prognostic value of different combinations of CD3- and CD8-positive immune cells in CRC patients. METHODS: The densities of CD3- and CD8-positive cells in intratumoral and stromal tissues were evaluated from 539 patients, for which we calculated a CD3 tumor–stroma index, a CD8 tumor–stroma index, and a CD3–CD8 tumor–stroma index. RESULTS: High CD3 and CD8 tumor–stroma indices associated with stage I to II disease ( p < 0.001 for both). The CD3 tumor–stroma index associated with a colonic tumor location ( p = 0.006), while the CD8 tumor–stroma index associated with right-sided tumors ( p < 0.001) and histological grade 3 tumors ( p = 0.032). High intratumoral and stromal densities for CD3- and CD8-positive immune cells, the CD3 tumor–stroma index, the CD8 tumor–stroma index, and the CD3–CD8 tumor–stroma index all indicated a better DSS. CONCLUSIONS: The CD3 tumor–stroma index carries a strong prognostic value in CRC, and none of the CD3 and CD8 combinations we analyzed proved superior.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Translational Cancer Medicine Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
- Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- Department of Oral Pathology and Radiology, University of Turku, Turku, Finland.
- Department of Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Zitieren
APA
Kasurinen, J., Hagström, J., Kaprio, T., Beilmann-Lehtonen, I., Haglund, C., & Böckelman, C. (2022). Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8 + -to-CD3 + ratio remains debatable. Tumor Biology, 44(1), 37-52. https://doi.org/10.3233/tub-211571
Vancouver
Kasurinen J, Hagström J, Kaprio T, Beilmann-Lehtonen I, Haglund C, Böckelman C. Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8 + -to-CD3 + ratio remains debatable. Tumor Biology. 2022;44(1):37-52. doi:10.3233/tub-211571
BibTeX
@article{Kasurinen2022,
author = {Kasurinen, Jussi and Hagström, Jaana and Kaprio, Tuomas and Beilmann-Lehtonen, Ines and Haglund, Caj and Böckelman, Camilla},
title = {Tumor-associated CD3- and CD8-positive immune cells in colorectal cancer: The additional prognostic value of CD8 + -to-CD3 + ratio remains debatable},
journal = {Tumor Biology},
year = {2022},
volume = {44},
number = {1},
pages = {37--52},
doi = {10.3233/tub-211571}
}
EUVIMED